The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Everolimus plus exemestane in patients with advanced invasive lobular carcinoma: Efficacy and safety results from BOLERO-2.
 
Gabriel N. Hortobagyi
Consulting or Advisory Role - Amgen; Antigen Express; AstraZeneca; Galena Biopharma; Genentech; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Shinzaburo Noguchi
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Eisai; Nippon Kayaku; Novartis; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - Novartis; Taiho Pharmaceutical
Research Funding - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Nippon Kayaku; Novartis; Pfizer; Sanofi; Taiho Pharmaceutical; Takeda
 
Patrick Neven
No Relationships to Disclose
 
Puttisak Puttawibul
No Relationships to Disclose
 
Daniel Heng
Consulting or Advisory Role - Bayer; Novartis; Pfizer
 
Thomas Brechenmacher
Employment - Novartis
 
Francois Philippe Ringeisen
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Stephen Saletan
Employment - Novartis
 
Thomas Denis Bachelot
Honoraria - Novartis
Consulting or Advisory Role - Novartis
Research Funding - Novartis